Cargando…
From Kinase Inhibitors to Multitarget Ligands as Powerful Drug Leads for Alzheimer's Disease using Protein‐Templated Synthesis
Multitarget directed ligands (MTDLs) are arising as promising tools to tackle complex diseases. The main goal of this work is to create powerful modulating agents for neurodegenerative disorders. To achieve this aim, we have combined fragments that inhibit key protein kinases involved in the main pa...
Autores principales: | Nozal, Vanesa, García‐Rubia, Alfonso, Cuevas, Eva P., Pérez, Concepción, Tosat‐Bitrián, Carlota, Bartolomé, Fernando, Carro, Eva, Ramírez, David, Palomo, Valle, Martínez, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457121/ https://www.ncbi.nlm.nih.gov/pubmed/34169618 http://dx.doi.org/10.1002/anie.202106295 |
Ejemplares similares
-
TTBK1 and CK1 inhibitors restore TDP-43 pathology and avoid disease propagation in lymphoblast from Alzheimer’s disease patients
por: Martinez-Gonzalez, Loreto, et al.
Publicado: (2023) -
Increasing Brain Permeability of PHA-767491, a Cell Division Cycle 7 Kinase Inhibitor, with Biodegradable Polymeric Nanoparticles
por: Rojas-Prats, Elisa, et al.
Publicado: (2021) -
CdSe Quantum Dots in Human Models Derived from ALS Patients: Characterization, Nuclear Penetration Studies and Multiplexing
por: Tosat-Bitrián, Carlota, et al.
Publicado: (2021) -
Nanomedical research and development in Spain: improving the treatment of diseases from the nanoscale
por: Fernández-Gómez, Paula, et al.
Publicado: (2023) -
A Definition of “Multitargeticity”: Identifying Potential Multitarget and Selective Ligands Through a Vector Analysis
por: Sánchez-Tejeda, Juan Francisco, et al.
Publicado: (2020)